Jefferies Financial Group Inc.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 96223
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$339,889
-$759,398 QoQ
Shares Held
633
-69.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#275
of 411 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Dec 31, 2024CallValue
$308,570
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. MDGL ranks #54 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
466,258 | $26,679,282 |
All Filings in MDGL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,889 | 633 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $1,099,287 | 2,100 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,339,382 | 2,300 | Shares | Defined | 2026-02-09 | |
| 2024-12-31 | $308,570 | 1,000 | Call | Defined | 2025-02-27 | |
| 2024-12-31 | $77,142 | 250 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $21,222 | 100 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $74,701 | 352 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $212,220 | 1,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $280,160 | 1,000 | Call | Defined | 2024-08-13 | |
| 2024-03-31 | $267,040 | 1,000 | Call | Defined | 2024-05-13 | |
| 2023-12-31 | $1,434,556 | 6,200 | Call | Defined | 2024-05-06 | |
| 2023-09-30 | $788,616 | 5,400 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $63,294 | 274 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $1,362,900 | 5,900 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $678,328 | 2,800 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $327,777 | 1,353 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,234,925 | 7,700 | Put | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||